Moreover, expression of Syk is increased in SLE T cells and skin lesions of lupus MRL/lpr mice (44, 45), while administration of Syk inhibitors ameliorates kidney injury in lupus-prone mice (44). Here, SYK is linked to systemic lupus erythematosus.